Evidence map›Paper›PMID 35535094›Full record

ArticleJournal of clinical and experimental hepatology

Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel Survey.

Issah Younossi, Maria Stepanova, Mercedes Walters, Pegah Golabi, Manirath Srishord, Zobair M Younossi

Abstract read
In one paragraph

Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Issah YounossiBetty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.
Maria StepanovaBetty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.
Mercedes WaltersCenter for Outcomes Research in Liver Diseases, Washington DC, United States.
Pegah GolabiBetty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.
Manirath SrishordBetty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.
Zobair M YounossiBetty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Worldwide, liver cancer (LC) is the fifth and third most common type of cancer and cancer-related mortality, respectively. Our aim was to assess health-related quality of life (HRQL) and resource utilization in chronic liver disease (CLD) patients with LC. Methods: We used the Medical Expenditure Panel Survey 2004-2013. All patients had HRQL (Short Form-12, Patient Health Questionnaire-2, Kessler Psychological Distress Scale) and resource utilization data. We used patients with CLD without LC and colon cancer (CC) as controls. Results: A total of 1882 CLD patients (53 ± 14 years, 45% male, 53% white, 15% black, 23% Hispanic, 6% Asian, 42% employed, 48% private insurance, and 11% uninsured) were included. Of the cohort, 102 (5.4%) patients had LC. LC patients were older, more likely to be male and white, less employed but less likely uninsured than CLD patients without LC (all Conclusion: While having CLD causes impairment of patients' HRQL, LC further adds to this impairment and also contributes to a substantial resource utilization.

Indexed as

CC, Colon cancerCLD, Chronic liver diseasedisease burdenHCC, hepatocellular carcinomaHRQL, Health-related quality-of-lifeLC, Liver cancerLD, Liver diseaseLT, Liver transplantationMEPS, Medical Expenditure Panel Surveymetabolic syndromenational surveyoutcomespatient-reported outcomesQoL, quality of lifeSEER, Surveillance, Epidemiology, and End Results Program

Identifiers

PMID35535094
PMCPMC9077230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.